Stromal cell–derived chemokines modulate immune cells in inflammation: New findings and future perspectives
The Journal of Immunology · 2025
DOI: 10.1093/jimmun/vkaf136 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Bo Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, Department of Orthodontics, West China Hospital of Sto…. Hauptthemen laut MEDLINE: Inflammation, Chemokines, Stromal Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 155 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province, Fundamental Research Funds for the Central Universities, Research and Develop Program.
Abstract (Originalsprache)
Tissue stromal cells are composed of numerous cell types with phenotypical and functional heterogeneity. Apart from providing structural support, they are emerging as key orchestrators of both activation and repression of immune responses in tissue microenvironment. The underlying mechanisms by which stromal cells contribute to immunomodulation are multifaceted, in which the chemokine-mediated interactions with immune cells have drawn great attention. The distinct stromal cell subpopulations can change the chemokine secretion profiles to regulate the recruitment and activation of immune cells in the onset and progression of inflammation. Elucidation of the mechanisms of the homeostatic and pathogenic stromal-immune cell interactions via chemokines can assist in the identification of novel therapeutic targets for modulating inflammatory diseases and enhancing the efficacy of cancer immunotherapy. Therefore, the current review highlights the updated understanding of the stromal-immune interactions via chemokines in inflammation, as well as potential therapeutic avenues to target at the intercellular crosstalk for inflammatory disorders and cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, Department of Orthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
ORCID-Profile: Bo Zhang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Sichuan Province
- Fundamental Research Funds for the Central Universities, Research and Develop Program
- West China Hospital of Stomatology Sichuan University
- China Postdoctoral Science Foundation
Zitieren
APA
Zhang, B., Wang, R., Tao, S., Zhu, Y., Luo, W., Yang, Y., Li, Y., Zhou, K., & Zhao, Z. (2025). Stromal cell–derived chemokines modulate immune cells in inflammation: New findings and future perspectives. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf136
Vancouver
Zhang B, Wang R, Tao S, Zhu Y, Luo W, Yang Y, et al. Stromal cell–derived chemokines modulate immune cells in inflammation: New findings and future perspectives. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkaf136
BibTeX
@article{Zhang2025,
author = {Zhang, Bo and Wang, Ruojing and Tao, Shihan and Zhu, Yujie and Luo, Wenxin and Yang, Yiyan and Li, Yifei and Zhou, Kaiyu and Zhao, Zhihe},
title = {Stromal cell–derived chemokines modulate immune cells in inflammation: New findings and future perspectives},
journal = {The Journal of Immunology},
year = {2025},
doi = {10.1093/jimmun/vkaf136}
}
EUVIMED